Nasal route favors the induction of CD4+ T cell responses in the liver of HBV‐carrier mice immunized with a recombinant hepatitis B surface‐ and core‐based therapeutic vaccine
Sign Up to like & getrecommendations! Published in 2018 at "Antiviral Research"
DOI: 10.1016/j.antiviral.2018.02.019
Abstract: &NA; Immunization routes and number of doses remain largely unexplored in therapeutic vaccination. The aim of the present work is to evaluate their impact on immune responses in naïve and hepatitis B virus (HBV)‐carrier mouse… read more here.
Keywords: carrier mice; hbv carrier; mice immunized; carrier ... See more keywords